We observed that the well differentiated tumor has significantly lower mutation frequency of EGFR (P = 5.25E-06, adjusted by Bonferroni’s correction) and TP53 (P = 3.54E-04, adjusted by Bonferroni’s correction) than moderately differentiated tumors (Table 2 and Fig. S7). The gene discussed is TP53; the disease is neoplasm.